<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sixty-one cases of <z:e sem="disease" ids="C0851807" disease_type="Disease or Syndrome" abbrv="">Aspergillus infection</z:e> (35 <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, 15 <z:hpo ids='HP_0006721'>acute lymphoid leukemia</z:hpo>, one <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, two <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, eight non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) seen in our department between January 1989 and July 1999 were studied retrospectively to evaluate the clinical characteristics, to ascertain the factors that influenced the outcome from mycotic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, and whether early diagnosis and prolonged therapy permitted completion of scheduled intensive chemotherapy and bone marrow transplantation (BMT) without fungal recurrence </plain></SENT>
<SENT sid="1" pm="."><plain>The patients were divided into three diagnostic categories: proven <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> (autoptic or histologic diagnosis) n = 39, probable <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> (radiological diagnosis with positive microbiology) n = 9, and possible <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> (radiological diagnosis alone) n = 13 </plain></SENT>
<SENT sid="2" pm="."><plain>In the same period among 675 <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> patients the incidence of proven or probable <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> was 7.1% </plain></SENT>
<SENT sid="3" pm="."><plain>At <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> 92% of patients were neutropenic (&lt; 0.5 x 10(9)/L) </plain></SENT>
<SENT sid="4" pm="."><plain>The most frequent site of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was the lung (90%); disseminated disease was present in 20 patients </plain></SENT>
<SENT sid="5" pm="."><plain>Among 44 assessable patients, 12 (27%) failed to respond to early antifungal therapy and died </plain></SENT>
<SENT sid="6" pm="."><plain>Thirty-two patients were cured with antifungal treatment, three of five nonneutropenic with only <z:chebi fb="0" ids="6076">itraconazole</z:chebi>, the others with <z:chebi fb="1" ids="2682">amphotericin B</z:chebi> 1 mg/Kg/day with or without <z:chebi fb="0" ids="6076">itraconazole</z:chebi> subsequently or with liposomal amphotericin, Ambisome, if renal toxicity occurred </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty-four of 29 neutropenic responders, <z:hpo ids='HP_0000001'>all</z:hpo> affected by <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, continued scheduled intensive chemotherapies </plain></SENT>
<SENT sid="8" pm="."><plain>Pulmonary lobectomy was successfully combined with medical treatment in two cases before scheduled BMT </plain></SENT>
<SENT sid="9" pm="."><plain>After <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> nine patients were submitted to BMT (six allo, one marrow unrelated donor (MUD), two auto) with Ambisome or <z:chebi fb="0" ids="6076">itraconazole</z:chebi> as secondary prophylaxis without fungal relapse (follow-up: 25-99 months) </plain></SENT>
<SENT sid="10" pm="."><plain>The median time from <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infection</z:e> to transplant was five months, range 3-10 </plain></SENT>
<SENT sid="11" pm="."><plain>Thirteen of 29 surviving patients had <z:hpo ids='HP_0001909'>leukemia</z:hpo> relapse, but only three (23%) of these showed also <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infection</z:e> recurrence </plain></SENT>
<SENT sid="12" pm="."><plain>In conclusion, a high index of suspicion and careful clinical and radiological examinations are the key to identifying infected patients early and to programming the following therapeutic steps </plain></SENT>
<SENT sid="13" pm="."><plain>Above <z:hpo ids='HP_0000001'>all</z:hpo> in <z:hpo ids='HP_0001909'>leukemia</z:hpo> patients, prompt and aggressive administration of antifungal agents seems to improve the outcome of invasive <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal disease</z:e> and to permit intensive chemotherapy completion and transplant </plain></SENT>
</text></document>